261
Views
60
CrossRef citations to date
0
Altmetric
Research Article

In Vitro Skin Permeation and Retention of Paromomycin from Liposomes for Topical Treatment of the Cutaneous Leishmaniasis

, , &
Pages 289-296 | Published online: 03 Nov 2004

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (14)

Kiany de Oliveira Firmino, Francielli Lima Dos Santos, Morgana Souza Marques, Bárbara Souza da Costa, Gabriela da Silva Collar, Juliana Caierão, Alexandre Meneghello Fuentefria, Irene Clemes Külkamp Guerreiro & Renata Vidor Contri. (2023) Nanometric Systems Containing Ozonated Oil with Potential Activity against Skin Pathogens. Ozone: Science & Engineering 45:4, pages 398-409.
Read now
Enam A. Khalil, Mahmoud Y. Alkawareek, Ghadeer Othman, Bayan Tbakhi & Amal G. Al-Bakri. (2019) Evaluation of paromomycin sulphate permeation using ex vivo human skin model. Pharmaceutical Development and Technology 24:3, pages 390-393.
Read now
Jun Shi, Yanting Wu, Siyi Guo, Huidi Zhang, Guitian Chen & Xiaoqi Xu. (2019) The efficacy of anti-VEGF antibody-modified liposomes loaded with paeonol in the prevention and treatment of hypertrophic scars. Drug Development and Industrial Pharmacy 45:3, pages 439-455.
Read now
Gagandeep Manchanda, Rupinder Kaur Sodhi, Upendra Kumar Jain, Ramesh Chandra & Jitender Madan. (2018) Iodinated curcumin bearing dermal cream augmented drug delivery, antimicrobial and antioxidant activities. Journal of Microencapsulation 35:1, pages 49-61.
Read now
Amit Verma, Ankit Jain, Pooja Hurkat & Sanjay K Jain. (2016) Transfollicular drug delivery: current perspectives. Research and Reports in Transdermal Drug Delivery 5, pages 1-17.
Read now
Sveinung G. Ingebrigtsen, Nataša Škalko-Basnet & Ann Mari Holsæter. (2016) Development and optimization of a new processing approach for manufacturing topical liposomes-in-hydrogel drug formulations by dual asymmetric centrifugation. Drug Development and Industrial Pharmacy 42:9, pages 1375-1383.
Read now
Virginia Campani, Dario Marchese, Maria Teresa Pitaro, Michele Pitaro, Paolo Grieco & Giuseppe De Rosa. (2014) Development of a liposome-based formulation for vitamin K1 nebulization on the skin. International Journal of Nanomedicine 9, pages 1823-1832.
Read now
Esther Moreno, Juana Schwartz, Celia Fernández, Carmen Sanmartín, Paul Nguewa, Juan Manuel Irache & Socorro Espuelas. (2014) Nanoparticles as multifunctional devices for the topical treatment of cutaneous leishmaniasis. Expert Opinion on Drug Delivery 11:4, pages 579-597.
Read now
Arash Momeni, Morteza Rasoolian, Amir Momeni, Ali Navaei, Shahriar Emami, Zahra Shaker, Mehdi Mohebali & Alireza Khoshdel. (2013) Development of liposomes loaded with anti-leishmanial drugs for the treatment of cutaneous leishmaniasis. Journal of Liposome Research 23:2, pages 134-144.
Read now
Jun Shi, Fangli Ma, Xiaoyan Wang, Fang Wang & Huawei Liao. (2012) Formulation of liposomes gels of paeonol for transdermal drug delivery by Box-Behnken statistical design. Journal of Liposome Research 22:4, pages 270-278.
Read now
Guilherme Carneiro, Marta Gontijo Aguiar, Ana Paula Fernandes & Lucas Antônio Miranda Ferreira. (2012) Drug delivery systems for the topical treatment of cutaneous leishmaniasis . Expert Opinion on Drug Delivery 9:9, pages 1083-1097.
Read now
Isabel R.L. Nogueira, Guilherme Carneiro, Maria Irene Yoshida, Renata B. de Oliveira & Lucas A.M. Ferreira. (2011) Preparation, characterization, and topical delivery of paromomycin ion pairing. Drug Development and Industrial Pharmacy 37:9, pages 1083-1089.
Read now
Guilherme Carneiro, Delia C.M. Santos, Monica C. Oliveira, Ana P. Fernandes, Luciana S. Ferreira, Gilson A. Ramaldes, Elziria A. Nunan & Lucas A.M. Ferreira. (2010) Topical delivery and in vivo antileishmanial activity of paromomycin-loaded liposomes for treatment of cutaneous leishmaniasis. Journal of Liposome Research 20:1, pages 16-23.
Read now
Eder L Romero & Maria Jose Morilla. (2008) Drug delivery systems against leishmaniasis? Still an open question. Expert Opinion on Drug Delivery 5:7, pages 805-823.
Read now

Articles from other publishers (46)

Daniela Maza Vega, Magalí Di Meglio, Silvia del Valle Alonso, Fernando Alvira & Jorge Montanari. (2023) Nanomaterials for diagnosis, treatment, and prevention of human cutaneous leishmaniasis: A review. OpenNano 12, pages 100158.
Crossref
Nilesh Gorde, Sandeep O. Waghulde, Ajay Kharche & Mohan Kale. 2023. Advances in Novel Formulations for Drug Delivery. Advances in Novel Formulations for Drug Delivery 177 195 .
Felipe Francisco Tuon, Leticia Ramos Dantas, Regina Maia de Souza, Victoria Stadler Tasca Ribeiro & Valdir Sabbaga Amato. (2022) Liposomal drug delivery systems for the treatment of leishmaniasis. Parasitology Research 121:11, pages 3073-3082.
Crossref
Kashif Iqbal, Sidra Khalid, Craig A McElroy, Muhammad Adnan, Gul Majid Khan & M Junaid Dar. (2022) Triple-combination therapy for cutaneous leishmaniasis using detergent-free, hyaluronate-coated elastic nanovesicles. Nanomedicine 17:20, pages 1429-1447.
Crossref
Nowsheen Goonoo, Marie Andrea Laetitia Huët, Itisha Chummun, Nancy Karuri, Kingsley Badu, Fanny Gimié, Jonas Bergrath, Margit Schulze, Mareike Müller & Archana Bhaw-Luximon. (2022) Nanomedicine-based strategies to improve treatment of cutaneous leishmaniasis. Royal Society Open Science 9:6.
Crossref
Sandra Milena Leal Pinto, Luis Alexandre Muehlmann, Lucía Liliana Mantilla Ojeda, Angélica María Vera Arias, Martha Viviana Roa Cordero, María de Fátima Menezes Almeida Santos, Ricardo Bentes Azevedo & Patricia Escobar Rivero. (2021) Nanoemulsions with Chloroaluminium Phthalocyanine and Paromomycin for Combined Photodynamic and Antibiotic Therapy for Cutaneous Leishmaniasis. Infection & Chemotherapy 53:2, pages 342.
Crossref
Madhusudhan Alle, Noufel Samed & Jin-Chul Kim. 2021. Smart Nanomaterials in Biomedical Applications. Smart Nanomaterials in Biomedical Applications 449 486 .
Mohammad Imani & Azam Dehghan. 2020. Nanobiotechnology in Diagnosis, Drug Delivery, and Treatment. Nanobiotechnology in Diagnosis, Drug Delivery, and Treatment 295 357 .
Ali Aghajani, Tabassom Kazemi, Reza Enayatifard, Fereshteh Talebpour Amiri & Mahsa Narenji. (2020) Investigating the skin penetration and wound healing properties of niosomal pentoxifylline cream. European Journal of Pharmaceutical Sciences 151, pages 105434.
Crossref
Linna B. O. Rodrigues, Flávia A. Lima, Camila P. B. Alves, Elisângela Martins-Santos, Marta M. G. Aguiar, Cleida A. Oliveira, Rodrigo L. Oréfice, Lucas A. M. Ferreira & Gisele A. C. Goulart. (2020) Ion Pair Strategy in Solid Lipid Nanoparticles: a Targeted Approach to Improve Epidermal Targeting with Controlled Adapalene Release, Resulting Reduced Skin Irritation. Pharmaceutical Research 37:8.
Crossref
A.P.S. Matos, A.L. Viçosa, M.I. Ré, E. Ricci-Júnior & C. Holandino. (2020) A review of current treatments strategies based on paromomycin for leishmaniasis. Journal of Drug Delivery Science and Technology 57, pages 101664.
Crossref
Peeyush Bhardwaj, Purnima Tripathi, Rishikesh Gupta & Sonia Pandey. (2020) Niosomes: A review on niosomal research in the last decade. Journal of Drug Delivery Science and Technology 56, pages 101581.
Crossref
Nour Elhouda Ben Ammar, Rym Essid, Taieb Saied, Murat Şen, Salem Elkahoui & Ahmed Hichem Hamzaoui. (2019) Synthesis and characterization of radiation cross-linked PVP hydrogels and investigation of its potential as an antileishmanial drug carrier. Polymer Bulletin 77:3, pages 1343-1357.
Crossref
Alam Zeb, Sadia Tabassam Arif, Maimoona Malik, Fawad Ali Shah, Fakhar Ud Din, Omer Salman Qureshi, Eun-Sun Lee, Gwan-Yeong Lee & Jin-Ki Kim. (2018) Potential of nanoparticulate carriers for improved drug delivery via skin. Journal of Pharmaceutical Investigation 49:5, pages 485-517.
Crossref
Seyedeh Alia Moosavian, Maryam Fallah & Mahmoud Reza Jaafari. (2019) The activity of encapsulated meglumine antimoniate in stearylamine-bearing liposomes against cutaneous leishmaniasis in BALB/c mice. Experimental Parasitology 200, pages 30-35.
Crossref
Ana Beatriz C. Santos-Valle, Gabriela R.R. Souza, Camila Q. Paes, Takuya Miyazaki, Adny Henrique Silva, Maria J. Altube, Maria J. Morilla, Eder L. Romero, Tânia B. Creczynski-Pasa, Horacio Cabral & Frederico Pittella. (2019) Nanomedicine strategies for addressing major needs in neglected tropical diseases. Annual Reviews in Control 48, pages 423-441.
Crossref
Gul Shahnaz, Hafiz Shoaib Sarwar & Masoom Yasinzai. 2018. Leishmaniases as Re-emerging Diseases. Leishmaniases as Re-emerging Diseases.
Katrien Van Bocxlaer, Eric Gaukel, Deirdre Hauser, Seong Hee Park, Sara Schock, Vanessa Yardley, Ryan Randolph, Jacob J. Plattner, Tejal Merchant, Simon L. Croft, Robert T. Jacobs & Stephen A. Wring. (2018) Topical Treatment for Cutaneous Leishmaniasis: Dermato-Pharmacokinetic Lead Optimization of Benzoxaboroles. Antimicrobial Agents and Chemotherapy 62:5.
Crossref
Kunat Suktham, Thongchai Koobkokkruad, Tuksadon Wutikhun & Suvimol Surassmo. (2018) Efficiency of resveratrol-loaded sericin nanoparticles: Promising bionanocarriers for drug delivery. International Journal of Pharmaceutics 537:1-2, pages 48-56.
Crossref
. 2017. Carrier‒Mediated Dermal Delivery. Carrier‒Mediated Dermal Delivery 385 430 .
Malti Arya, Prakash Tiwari, Chandra Bhushan Tripathi, Poonam Parashar, Mahendra Singh, Priyam Sinha, Narayan P. Yadav, Gaurav Kaithwas, Krishna P. Gupta & Shubhini A. Saraf. (2017) Colloidal Vesicular System of Inositol Hexaphosphate to Counteract DMBA Induced Dysregulation of Markers Pertaining to Cellular Proliferation/Differentiation and Inflammation of Epidermal Layer in Mouse Model. Molecular Pharmaceutics 14:3, pages 928-939.
Crossref
Kunat Suktham, Thongchai Koobkokkruad, Somsak Saesoo, Nattika Saengkrit & Suvimol Surassmo. (2016) Physical and biological characterization of sericin-loaded copolymer liposomes stabilized by polyvinyl alcohol. Colloids and Surfaces B: Biointerfaces 148, pages 487-495.
Crossref
Maryam Heidari Kharaji, Delaram Doroud, Tahereh Taheri & Sima Rafati. (2015) Drug Targeting to Macrophages With Solid Lipid Nanoparticles Harboring Paromomycin: an In Vitro Evaluation Against L. major and L. tropica. AAPS PharmSciTech 17:5, pages 1110-1119.
Crossref
M. Heidari-Kharaji, T. Taheri, D. Doroud, S. Habibzadeh, A. Badirzadeh & S. Rafati. (2016) Enhanced paromomycin efficacy by solid lipid nanoparticle formulation against Leishmania in mice model . Parasite Immunology 38:10, pages 599-608.
Crossref
Maryam Heidari-Kharaji, Tahereh Taheri, Delaram Doroud, Sima Habibzadeh & Sima Rafati. (2016) Solid lipid nanoparticle loaded with paromomycin: in vivo efficacy against Leishmania tropica infection in BALB/c mice model. Applied Microbiology and Biotechnology 100:16, pages 7051-7060.
Crossref
S. Espuelas, J. Schwartz & E. Moreno. 2016. Nanoscience in Dermatology. Nanoscience in Dermatology 135 155 .
Andrew Basnett, Tuyet A. Nguyen, Christopher Cannavino & Andrew C. Krakowski. (2015) Ablative fractional laser resurfacing with topical paromomycin as adjunctive treatment for a recalcitrant cutaneous leishmaniasis wound. Lasers in Surgery and Medicine 47:10, pages 788-791.
Crossref
Heibatullah Kalantari, Ali Asghar Hemmati, Neda Bavarsad, Annahita Rezaie & Shahin Ahmadi. (2014) Effect of topical Nanoliposomes of Paromomycin on Rats Liver and Kidney. Jundishapur Journal of Natural Pharmaceutical Products 9:4.
Crossref
Juana Schwartz, Esther Moreno, Celia Fernández, Iñigo Navarro-Blasco, Paul A. Nguewa, Juan A. Palop, Juan M. Irache, Carmen Sanmartín & Socorro Espuelas. (2014) Topical treatment of L. major infected BALB/c mice with a novel diselenide chitosan hydrogel formulation. European Journal of Pharmaceutical Sciences 62, pages 309-316.
Crossref
S.A. Moosavian Kalat, A. Khamesipour, N. Bavarsad, M. Fallah, Z. Khashayarmanesh, E. Feizi, K. Neghabi, A. Abbasi & M.R. Jaafari. (2014) Use of topical liposomes containing meglumine antimoniate (Glucantime) for the treatment of L. major lesion in BALB/c mice. Experimental Parasitology 143, pages 5-10.
Crossref
William R. Ravis, Alejandro Llanos-Cuentas, Nestor Sosa, Mara Kreishman-Deitrick, Karen M. Kopydlowski, Carl Nielsen, Kirsten S. Smith, Philip L. Smith, Janet H. Ransom, Yuh-Jing Lin & Max Grogl. (2013) Pharmacokinetics and Absorption of Paromomycin and Gentamicin from Topical Creams Used To Treat Cutaneous Leishmaniasis. Antimicrobial Agents and Chemotherapy 57:10, pages 4809-4815.
Crossref
Wahid Khan, Shyam S. Sharma & Neeraj Kumar. (2012) Bioanalytical method development, pharmacokinetics, and toxicity studies of paromomycin and paromomycin loaded in albumin microspheres. Drug Testing and Analysis 5:6, pages 453-460.
Crossref
Philippe M. Loiseau & Gillian Barratt. 2013. Drug Resistance in Leishmania Parasites. Drug Resistance in Leishmania Parasites 321 350 .
Neda Bavarsad, Bibi Sedigheh Fazly Bazzaz, Ali Khamesipour & Mahmoud Reza Jaafari. (2012) Colloidal, in vitro and in vivo anti-leishmanial properties of transfersomes containing paromomycin sulfate in susceptible BALB/c mice. Acta Tropica 124:1, pages 33-41.
Crossref
Maryam Ghadiri, Shohreh Fatemi, Alireza Vatanara, Delaram Doroud, Abdolhossein Rouholamini Najafabadi, Majid Darabi & Amir Abbas Rahimi. (2012) Loading hydrophilic drug in solid lipid media as nanoparticles: Statistical modeling of entrapment efficiency and particle size. International Journal of Pharmaceutics 424:1-2, pages 128-137.
Crossref
Maryam Ghadiri, Alireza Vatanara, Delaram Doroud & A. Roholamini Najafabadi. (2011) Paromomycin loaded solid lipid nanoparticles: Characterization of production parameters. Biotechnology and Bioprocess Engineering 16:3, pages 617-623.
Crossref
Wahid Khan & Neeraj Kumar. (2011) Characterization, thermal stability studies, and analytical method development of Paromomycin for formulation development. Drug Testing and Analysis 3:6, pages 363-372.
Crossref
Carl Simonsson, Jakob Torp Madsen, Annette Graneli, Klaus E. Andersen, Ann-Therese Karlberg, Charlotte A. Jonsson & Marica B. Ericson. (2011) A study of the enhanced sensitizing capacity of a contact allergen in lipid vesicle formulations. Toxicology and Applied Pharmacology 252:3, pages 221-227.
Crossref
Antara Banerjee, Manjarika De & Nahid Ali. (2011) Combination Therapy with Paromomycin-Associated Stearylamine-Bearing Liposomes Cures Experimental Visceral Leishmaniasis through Th1-Biased Immunomodulation. Antimicrobial Agents and Chemotherapy 55:4, pages 1661-1670.
Crossref
M. G. Aguiar, D. L. Silva, F. A. Nunan, E. A. Nunan, A. P. Fernandes & L. A. M. Ferreira. (2009) Combined topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) major leads to reduction in both lesion size and systemic parasite burdens. Journal of Antimicrobial Chemotherapy 64:6, pages 1234-1240.
Crossref
Pankaj Karande & Samir Mitragotri. (2009) Enhancement of transdermal drug delivery via synergistic action of chemicals. Biochimica et Biophysica Acta (BBA) - Biomembranes 1788:11, pages 2362-2373.
Crossref
Mahmoud R. Jaafari, Neda Bavarsad, Bibi Sedigheh Fazly Bazzaz, Afshin Samiei, Dina Soroush, Serajodin Ghorbani, Mohammad M. Lotfi Heravi & Ali Khamesipour. (2009) Effect of Topical Liposomes Containing Paromomycin Sulfate in the Course of Leishmania major Infection in Susceptible BALB/c Mice . Antimicrobial Agents and Chemotherapy 53:6, pages 2259-2265.
Crossref
J. A. SCHLEINING, S. R. McCLURE, R. B. EVANS, W. G. HYDE, L. W. WULF & A. J. KIND. (2008) Liposome-based diclofenac for the treatment of inflammation in an acute synovitis model in horses. Journal of Veterinary Pharmacology and Therapeutics 31:6, pages 554-561.
Crossref
Mustafa M.A. Elsayed, Ossama Y. Abdallah, Viviane F. Naggar & Nawal M. Khalafallah. (2007) Lipid vesicles for skin delivery of drugs: Reviewing three decades of research. International Journal of Pharmaceutics 332:1-2, pages 1-16.
Crossref
M.J. Choi & H.I. Maibach. (2005) Liposomes and Niosomes as Topical Drug Delivery Systems. Skin Pharmacology and Physiology 18:5, pages 209-219.
Crossref
Abeer A.W. Elzainy, Xiaochen Gu, F. Estelle R. Simons & Keith J. Simons. (2004) Cetirizine from topical phosphatidylcholine liposomes: Evaluation of peripheral antihistaminic activity and systemic absorption in a rabbit model. Biopharmaceutics & Drug Disposition 25:8, pages 359-366.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.